BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 27911851)

  • 1. Inherited variants affecting RNA editing may contribute to ovarian cancer susceptibility: results from a large-scale collaboration.
    Permuth JB; Reid B; Earp M; Chen YA; Monteiro AN; Chen Z; ; Chenevix-Trench G; Fasching PA; Beckmann MW; Lambrechts D; Vanderstichele A; Van Niewenhuyse E; Vergote I; Rossing MA; Doherty JA; Chang-Claude J; Moysich K; Odunsi K; Goodman MT; Shvetsov YB; Wilkens LR; Thompson PJ; Dörk T; Bogdanova N; Butzow R; Nevanlinna H; Pelttari L; Leminen A; Modugno F; Edwards RP; Ness RB; Kelley J; Heitz F; Karlan B; Lester J; Kjaer SK; Jensen A; Giles G; Hildebrandt M; Liang D; Lu KH; Wu X; Levine DA; Bisogna M; Berchuck A; Cramer DW; Terry KL; Tworoger SS; Poole EM; Bandera EV; Fridley B; Cunningham J; Winham SJ; Olson SH; Orlow I; Bjorge L; Kiemeney LA; Massuger L; Pejovic T; Moffitt M; Le N; Cook LS; Brooks-Wilson A; Kelemen LE; Gronwald J; Lubinski J; Wentzensen N; Brinton LA; Lissowska J; Yang H; Hogdall E; Hogdall C; Lundvall L; Pharoah PD; Song H; Campbell I; Eccles D; McNeish I; Whittemore A; McGuire V; Sieh W; Rothstein J; Phelan CM; Risch H; Narod S; McLaughlin J; Anton-Culver H; Ziogas A; Menon U; Gayther S; Ramus SJ; Gentry-Maharaj A; Pearce CL; Wu AH; Kupryjanczyk J; Dansonka-Mieszkowska A; Schildkraut JM; Cheng JQ; Goode EL; Sellers TA
    Oncotarget; 2016 Nov; 7(45):72381-72394. PubMed ID: 27911851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk.
    Chornokur G; Lin HY; Tyrer JP; Lawrenson K; Dennis J; Amankwah EK; Qu X; Tsai YY; Jim HS; Chen Z; Chen AY; Permuth-Wey J; Aben KK; Anton-Culver H; Antonenkova N; Bruinsma F; Bandera EV; Bean YT; Beckmann MW; Bisogna M; Bjorge L; Bogdanova N; Brinton LA; Brooks-Wilson A; Bunker CH; Butzow R; Campbell IG; Carty K; Chang-Claude J; Cook LS; Cramer DW; Cunningham JM; Cybulski C; Dansonka-Mieszkowska A; du Bois A; Despierre E; Dicks E; Doherty JA; Dörk T; Dürst M; Easton DF; Eccles DM; Edwards RP; Ekici AB; Fasching PA; Fridley BL; Gao YT; Gentry-Maharaj A; Giles GG; Glasspool R; Goodman MT; Gronwald J; Harrington P; Harter P; Hein A; Heitz F; Hildebrandt MA; Hillemanns P; Hogdall CK; Hogdall E; Hosono S; Jakubowska A; Jensen A; Ji BT; Karlan BY; Kelemen LE; Kellar M; Kiemeney LA; Krakstad C; Kjaer SK; Kupryjanczyk J; Lambrechts D; Lambrechts S; Le ND; Lee AW; Lele S; Leminen A; Lester J; Levine DA; Liang D; Lim BK; Lissowska J; Lu K; Lubinski J; Lundvall L; Massuger LF; Matsuo K; McGuire V; McLaughlin JR; McNeish I; Menon U; Milne RL; Modugno F; Moysich KB; Ness RB; Nevanlinna H; Eilber U; Odunsi K; Olson SH; Orlow I; Orsulic S; Weber RP; Paul J; Pearce CL; Pejovic T; Pelttari LM; Pike MC; Poole EM; Risch HA; Rosen B; Rossing MA; Rothstein JH; Rudolph A; Runnebaum IB; Rzepecka IK; Salvesen HB; Schernhammer E; Schwaab I; Shu XO; Shvetsov YB; Siddiqui N; Sieh W; Song H; Southey MC; Spiewankiewicz B; Sucheston L; Teo SH; Terry KL; Thompson PJ; Thomsen L; Tangen IL; Tworoger SS; van Altena AM; Vierkant RA; Vergote I; Walsh CS; Wang-Gohrke S; Wentzensen N; Whittemore AS; Wicklund KG; Wilkens LR; Wu AH; Wu X; Woo YL; Yang H; Zheng W; Ziogas A; Hasmad HN; Berchuck A; ; ; Iversen ES; Schildkraut JM; Ramus SJ; Goode EL; Monteiro AN; Gayther SA; Narod SA; Pharoah PD; Sellers TA; Phelan CM
    PLoS One; 2015; 10(6):e0128106. PubMed ID: 26091520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inherited variants in mitochondrial biogenesis genes may influence epithelial ovarian cancer risk.
    Permuth-Wey J; Chen YA; Tsai YY; Chen Z; Qu X; Lancaster JM; Stockwell H; Dagne G; Iversen E; Risch H; Barnholtz-Sloan J; Cunningham JM; Vierkant RA; Fridley BL; Sutphen R; McLaughlin J; Narod SA; Goode EL; Schildkraut JM; Fenstermacher D; Phelan CM; Sellers TA
    Cancer Epidemiol Biomarkers Prev; 2011 Jun; 20(6):1131-45. PubMed ID: 21447778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. STAT3 polymorphisms may predict an unfavorable response to first-line platinum-based therapy for women with advanced serous epithelial ovarian cancer.
    Permuth-Wey J; Fulp WJ; Reid BM; Chen Z; Georgeades C; Cheng JQ; Magliocco A; Chen DT; Lancaster JM
    Int J Cancer; 2016 Feb; 138(3):612-9. PubMed ID: 26264211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Common variants at the CHEK2 gene locus and risk of epithelial ovarian cancer.
    Lawrenson K; Iversen ES; Tyrer J; Weber RP; Concannon P; Hazelett DJ; Li Q; Marks JR; Berchuck A; Lee JM; Aben KK; Anton-Culver H; Antonenkova N; ; ; Bandera EV; Bean Y; Beckmann MW; Bisogna M; Bjorge L; Bogdanova N; Brinton LA; Brooks-Wilson A; Bruinsma F; Butzow R; Campbell IG; Carty K; Chang-Claude J; Chenevix-Trench G; Chen A; Chen Z; Cook LS; Cramer DW; Cunningham JM; Cybulski C; Plisiecka-Halasa J; Dennis J; Dicks E; Doherty JA; Dörk T; du Bois A; Eccles D; Easton DT; Edwards RP; Eilber U; Ekici AB; Fasching PA; Fridley BL; Gao YT; Gentry-Maharaj A; Giles GG; Glasspool R; Goode EL; Goodman MT; Gronwald J; Harter P; Hasmad HN; Hein A; Heitz F; Hildebrandt MA; Hillemanns P; Hogdall E; Hogdall C; Hosono S; Jakubowska A; Paul J; Jensen A; Karlan BY; Kjaer SK; Kelemen LE; Kellar M; Kelley JL; Kiemeney LA; Krakstad C; Lambrechts D; Lambrechts S; Le ND; Lee AW; Cannioto R; Leminen A; Lester J; Levine DA; Liang D; Lissowska J; Lu K; Lubinski J; Lundvall L; Massuger LF; Matsuo K; McGuire V; McLaughlin JR; Nevanlinna H; McNeish I; Menon U; Modugno F; Moysich KB; Narod SA; Nedergaard L; Ness RB; Noor Azmi MA; Odunsi K; Olson SH; Orlow I; Orsulic S; Pearce CL; Pejovic T; Pelttari LM; Permuth-Wey J; Phelan CM; Pike MC; Poole EM; Ramus SJ; Risch HA; Rosen B; Rossing MA; Rothstein JH; Rudolph A; Runnebaum IB; Rzepecka IK; Salvesen HB; Budzilowska A; Sellers TA; Shu XO; Shvetsov YB; Siddiqui N; Sieh W; Song H; Southey MC; Sucheston L; Tangen IL; Teo SH; Terry KL; Thompson PJ; Timorek A; Tworoger SS; Van Nieuwenhuysen E; Vergote I; Vierkant RA; Wang-Gohrke S; Walsh C; Wentzensen N; Whittemore AS; Wicklund KG; Wilkens LR; Woo YL; Wu X; Wu AH; Yang H; Zheng W; Ziogas A; Coetzee GA; Freedman ML; Monteiro AN; Moes-Sosnowska J; Kupryjanczyk J; Pharoah PD; Gayther SA; Schildkraut JM
    Carcinogenesis; 2015 Nov; 36(11):1341-53. PubMed ID: 26424751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between PIWIL1 gene polymorphisms and epithelial ovarian cancer susceptibility among southern Chinese woman: a three-center case-control study.
    Liu S; Yan Y; Cui Z; Feng H; Zhong F; Liu Z; Li Y; Ou X; Li W
    BMC Cancer; 2023 Nov; 23(1):1149. PubMed ID: 38012622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31.
    Permuth-Wey J; Lawrenson K; Shen HC; Velkova A; Tyrer JP; Chen Z; Lin HY; Chen YA; Tsai YY; Qu X; Ramus SJ; Karevan R; Lee J; Lee N; Larson MC; Aben KK; Anton-Culver H; Antonenkova N; Antoniou AC; Armasu SM; ; ; Bacot F; Baglietto L; Bandera EV; Barnholtz-Sloan J; Beckmann MW; Birrer MJ; Bloom G; Bogdanova N; Brinton LA; Brooks-Wilson A; Brown R; Butzow R; Cai Q; Campbell I; Chang-Claude J; Chanock S; Chenevix-Trench G; Cheng JQ; Cicek MS; Coetzee GA; ; Cook LS; Couch FJ; Cramer DW; Cunningham JM; Dansonka-Mieszkowska A; Despierre E; Doherty JA; Dörk T; du Bois A; Dürst M; Easton DF; Eccles D; Edwards R; Ekici AB; Fasching PA; Fenstermacher DA; Flanagan JM; Garcia-Closas M; Gentry-Maharaj A; Giles GG; Glasspool RM; Gonzalez-Bosquet J; Goodman MT; Gore M; Górski B; Gronwald J; Hall P; Halle MK; Harter P; Heitz F; Hillemanns P; Hoatlin M; Høgdall CK; Høgdall E; Hosono S; Jakubowska A; Jensen A; Jim H; Kalli KR; Karlan BY; Kaye SB; Kelemen LE; Kiemeney LA; Kikkawa F; Konecny GE; Krakstad C; Kjaer SK; Kupryjanczyk J; Lambrechts D; Lambrechts S; Lancaster JM; Le ND; Leminen A; Levine DA; Liang D; Lim BK; Lin J; Lissowska J; Lu KH; Lubiński J; Lurie G; Massuger LF; Matsuo K; McGuire V; McLaughlin JR; Menon U; Modugno F; Moysich KB; Nakanishi T; Narod SA; Nedergaard L; Ness RB; Nevanlinna H; Nickels S; Noushmehr H; Odunsi K; Olson SH; Orlow I; Paul J; Pearce CL; Pejovic T; Pelttari LM; Pike MC; Poole EM; Raska P; Renner SP; Risch HA; Rodriguez-Rodriguez L; Rossing MA; Rudolph A; Runnebaum IB; Rzepecka IK; Salvesen HB; Schwaab I; Severi G; Shridhar V; Shu XO; Shvetsov YB; Sieh W; Song H; Southey MC; Spiewankiewicz B; Stram D; Sutphen R; Teo SH; Terry KL; Tessier DC; Thompson PJ; Tworoger SS; van Altena AM; Vergote I; Vierkant RA; Vincent D; Vitonis AF; Wang-Gohrke S; Palmieri Weber R; Wentzensen N; Whittemore AS; Wik E; Wilkens LR; Winterhoff B; Woo YL; Wu AH; Xiang YB; Yang HP; Zheng W; Ziogas A; Zulkifli F; Phelan CM; Iversen E; Schildkraut JM; Berchuck A; Fridley BL; Goode EL; Pharoah PD; Monteiro AN; Sellers TA; Gayther SA
    Nat Commun; 2013; 4():1627. PubMed ID: 23535648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenosine Deaminase That Acts on RNA 3 (ADAR3) Binding to Glutamate Receptor Subunit B Pre-mRNA Inhibits RNA Editing in Glioblastoma.
    Oakes E; Anderson A; Cohen-Gadol A; Hundley HA
    J Biol Chem; 2017 Mar; 292(10):4326-4335. PubMed ID: 28167531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diverse selective regimes shape genetic diversity at ADAR genes and at their coding targets.
    Forni D; Mozzi A; Pontremoli C; Vertemara J; Pozzoli U; Biasin M; Bresolin N; Clerici M; Cagliani R; Sironi M
    RNA Biol; 2015; 12(2):149-61. PubMed ID: 25826567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of vitamin D biosynthesis and pathway target genes reveals UGT2A1/2 and EGFR polymorphisms associated with epithelial ovarian cancer in African American Women.
    Grant DJ; Manichaikul A; Alberg AJ; Bandera EV; Barnholtz-Sloan J; Bondy M; Cote ML; Funkhouser E; Moorman PG; Peres LC; Peters ES; Schwartz AG; Terry PD; Wang XQ; Keku TO; Hoyo C; Berchuck A; Sandler DP; Taylor JA; O'Brien KM; Velez Edwards DR; Edwards TL; Beeghly-Fadiel A; Wentzensen N; Pearce CL; Wu AH; Whittemore AS; McGuire V; Sieh W; Rothstein JH; Modugno F; Ness R; Moysich K; Rossing MA; Doherty JA; Sellers TA; Permuth-Way JB; Monteiro AN; Levine DA; Setiawan VW; Haiman CA; LeMarchand L; Wilkens LR; Karlan BY; Menon U; Ramus S; Gayther S; Gentry-Maharaj A; Terry KL; Cramer DW; Goode EL; Larson MC; Kaufmann SH; Cannioto R; Odunsi K; Etter JL; Huang RY; Bernardini MQ; Tone AA; May T; Goodman MT; Thompson PJ; Carney ME; Tworoger SS; Poole EM; Lambrechts D; Vergote I; Vanderstichele A; Van Nieuwenhuysen E; Anton-Culver H; Ziogas A; Brenton JD; Bjorge L; Salvensen HB; Kiemeney LA; Massuger LFAG; Pejovic T; Bruegl A; Moffitt M; Cook L; Le ND; Brooks-Wilson A; Kelemen LE; Pharoah PDP; Song H; Campbell I; Eccles D; DeFazio A; Kennedy CJ; Schildkraut JM
    Cancer Med; 2019 May; 8(5):2503-2513. PubMed ID: 31001917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative analysis of ADAR mutant mice reveals site-specific regulation of RNA editing.
    Costa Cruz PH; Kato Y; Nakahama T; Shibuya T; Kawahara Y
    RNA; 2020 Apr; 26(4):454-469. PubMed ID: 31941663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epithelial-Mesenchymal Transition (EMT) Gene Variants and Epithelial Ovarian Cancer (EOC) Risk.
    Amankwah EK; Lin HY; Tyrer JP; Lawrenson K; Dennis J; Chornokur G; Aben KK; Anton-Culver H; Antonenkova N; Bruinsma F; Bandera EV; Bean YT; Beckmann MW; Bisogna M; Bjorge L; Bogdanova N; Brinton LA; Brooks-Wilson A; Bunker CH; Butzow R; Campbell IG; Carty K; Chen Z; Chen YA; Chang-Claude J; Cook LS; Cramer DW; Cunningham JM; Cybulski C; Dansonka-Mieszkowska A; du Bois A; Despierre E; Dicks E; Doherty JA; Dörk T; Dürst M; Easton DF; Eccles DM; Edwards RP; Ekici AB; Fasching PA; Fridley BL; Gao YT; Gentry-Maharaj A; Giles GG; Glasspool R; Goodman MT; Gronwald J; Harrington P; Harter P; Hasmad HN; Hein A; Heitz F; Hildebrandt MA; Hillemanns P; Hogdall CK; Hogdall E; Hosono S; Iversen ES; Jakubowska A; Jensen A; Ji BT; Karlan BY; Jim H; Kellar M; Kiemeney LA; Krakstad C; Kjaer SK; Kupryjanczyk J; Lambrechts D; Lambrechts S; Le ND; Lee AW; Lele S; Leminen A; Lester J; Levine DA; Liang D; Lim BK; Lissowska J; Lu K; Lubinski J; Lundvall L; Massuger LF; Matsuo K; McGuire V; McLaughlin JR; McNeish I; Menon U; Milne RL; Modugno F; Moysich KB; Ness RB; Nevanlinna H; Eilber U; Odunsi K; Olson SH; Orlow I; Orsulic S; Weber RP; Paul J; Pearce CL; Pejovic T; Pelttari LM; Permuth-Wey J; Pike MC; Poole EM; Risch HA; Rosen B; Rossing MA; Rothstein JH; Rudolph A; Runnebaum IB; Rzepecka IK; Salvesen HB; Schernhammer E; Schwaab I; Shu XO; Shvetsov YB; Siddiqui N; Sieh W; Song H; Southey MC; Spiewankiewicz B; Sucheston-Campbell L; Teo SH; Terry KL; Thompson PJ; Thomsen L; Tangen IL; Tworoger SS; van Altena AM; Vierkant RA; Vergote I; Walsh CS; Wang-Gohrke S; Wentzensen N; Whittemore AS; Wicklund KG; Wilkens LR; Wu AH; Wu X; Woo YL; Yang H; Zheng W; Ziogas A; Kelemen LE; Berchuck A; ; Schildkraut JM; Ramus SJ; Goode EL; Monteiro AN; Gayther SA; Narod SA; Pharoah PD; Sellers TA; Phelan CM
    Genet Epidemiol; 2015 Dec; 39(8):689-97. PubMed ID: 26399219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between common germline genetic variation in 94 candidate genes or regions and risks of invasive epithelial ovarian cancer.
    Quaye L; Tyrer J; Ramus SJ; Song H; Wozniak E; DiCioccio RA; McGuire V; Høgdall E; Høgdall C; Blaakaer J; Goode EL; Schildkraut JM; Easton DF; Krüger-Kjaer S; Whittemore AS; Gayther SA; Pharoah PD
    PLoS One; 2009 Jun; 4(6):e5983. PubMed ID: 19543528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenosine-to-inosine RNA editing: perspectives and predictions.
    Hoopengardner B
    Mini Rev Med Chem; 2006 Nov; 6(11):1213-6. PubMed ID: 17100632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNA binding by ADAR3 inhibits adenosine-to-inosine editing and promotes expression of immune response protein MAVS.
    Raghava Kurup R; Oakes EK; Manning AC; Mukherjee P; Vadlamani P; Hundley HA
    J Biol Chem; 2022 Sep; 298(9):102267. PubMed ID: 35850307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exome genotyping arrays to identify rare and low frequency variants associated with epithelial ovarian cancer risk.
    Permuth JB; Pirie A; Ann Chen Y; Lin HY; Reid BM; Chen Z; Monteiro A; Dennis J; Mendoza-Fandino G; ; ; Anton-Culver H; Bandera EV; Bisogna M; Brinton L; Brooks-Wilson A; Carney ME; Chenevix-Trench G; Cook LS; Cramer DW; Cunningham JM; Cybulski C; D'Aloisio AA; Anne Doherty J; Earp M; Edwards RP; Fridley BL; Gayther SA; Gentry-Maharaj A; Goodman MT; Gronwald J; Hogdall E; Iversen ES; Jakubowska A; Jensen A; Karlan BY; Kelemen LE; Kjaer SK; Kraft P; Le ND; Levine DA; Lissowska J; Lubinski J; Matsuo K; Menon U; Modugno R; Moysich KB; Nakanishi T; Ness RB; Olson S; Orlow I; Pearce CL; Pejovic T; Poole EM; Ramus SJ; Anne Rossing M; Sandler DP; Shu XO; Song H; Taylor JA; Teo SH; Terry KL; Thompson PJ; Tworoger SS; Webb PM; Wentzensen N; Wilkens LR; Winham S; Woo YL; Wu AH; Yang H; Zheng W; Ziogas A; Phelan CM; Schildkraut JM; Berchuck A; Goode EL; Pharoah PD; Sellers TA;
    Hum Mol Genet; 2016 Aug; 25(16):3600-3612. PubMed ID: 27378695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Origins and evolution of ADAR-mediated RNA editing.
    Jin Y; Zhang W; Li Q
    IUBMB Life; 2009 Jun; 61(6):572-8. PubMed ID: 19472181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer.
    Hampras SS; Sucheston-Campbell LE; Cannioto R; Chang-Claude J; Modugno F; Dörk T; Hillemanns P; Preus L; Knutson KL; Wallace PK; Hong CC; Friel G; Davis W; Nesline M; Pearce CL; Kelemen LE; Goodman MT; Bandera EV; Terry KL; Schoof N; Eng KH; Clay A; Singh PK; Joseph JM; Aben KK; Anton-Culver H; Antonenkova N; Baker H; Bean Y; Beckmann MW; Bisogna M; Bjorge L; Bogdanova N; Brinton LA; Brooks-Wilson A; Bruinsma F; Butzow R; Campbell IG; Carty K; Cook LS; Cramer DW; Cybulski C; Dansonka-Mieszkowska A; Dennis J; Despierre E; Dicks E; Doherty JA; du Bois A; Dürst M; Easton D; Eccles D; Edwards RP; Ekici AB; Fasching PA; Fridley BL; Gao YT; Gentry-Maharaj A; Giles GG; Glasspool R; Gronwald J; Harrington P; Harter P; Hasmad HN; Hein A; Heitz F; Hildebrandt MA; Hogdall C; Hogdall E; Hosono S; Iversen ES; Jakubowska A; Jensen A; Ji BT; Karlan BY; Kellar M; Kelley JL; Kiemeney LA; Klapdor R; Kolomeyevskaya N; Krakstad C; Kjaer SK; Kruszka B; Kupryjanczyk J; Lambrechts D; Lambrechts S; Le ND; Lee AW; Lele S; Leminen A; Lester J; Levine DA; Liang D; Lissowska J; Liu S; Lu K; Lubinski J; Lundvall L; Massuger LF; Matsuo K; McGuire V; McLaughlin JR; McNeish I; Menon U; Moes-Sosnowska J; Narod SA; Nedergaard L; Nevanlinna H; Nickels S; Olson SH; Orlow I; Weber RP; Paul J; Pejovic T; Pelttari LM; Perkins B; Permuth-Wey J; Pike MC; Plisiecka-Halasa J; Poole EM; Risch HA; Rossing MA; Rothstein JH; Rudolph A; Runnebaum IB; Rzepecka IK; Salvesen HB; Schernhammer E; Schmitt K; Schwaab I; Shu XO; Shvetsov YB; Siddiqui N; Sieh W; Song H; Southey MC; Tangen IL; Teo SH; Thompson PJ; Timorek A; Tsai YY; Tworoger SS; Tyrer J; van Altena AM; Vergote I; Vierkant RA; Walsh C; Wang-Gohrke S; Wentzensen N; Whittemore AS; Wicklund KG; Wilkens LR; Wu AH; Wu X; Woo YL; Yang H; Zheng W; Ziogas A; Gayther SA; Ramus SJ; Sellers TA; Schildkraut JM; Phelan CM; Berchuck A; Chenevix-Trench G; Cunningham JM; Pharoah PP; Ness RB; Odunsi K; Goode EL; Moysich KB
    Oncotarget; 2016 Oct; 7(43):69097-69110. PubMed ID: 27533245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.
    Lawrenson K; Song F; Hazelett DJ; Kar SP; Tyrer J; Phelan CM; Corona RI; Rodríguez-Malavé NI; Seo JH; Adler E; Coetzee SG; Segato F; Fonseca MAS; Amos CI; Carney ME; Chenevix-Trench G; Choi J; Doherty JA; Jia W; Jin GJ; Kim BG; Le ND; Lee J; Li L; Lim BK; Adenan NA; Mizuno M; Park B; Pearce CL; Shan K; Shi Y; Shu XO; Sieh W; ; Thompson PJ; Wilkens LR; Wei Q; Woo YL; Yan L; Karlan BY; Freedman ML; Noushmehr H; Goode EL; Berchuck A; Sellers TA; Teo SH; Zheng W; Matsuo K; Park S; Chen K; Pharoah PDP; Gayther SA; Goodman MT
    Gynecol Oncol; 2019 May; 153(2):343-355. PubMed ID: 30898391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Artificial RNA Editing with ADAR for Gene Therapy.
    Bhakta S; Tsukahara T
    Curr Gene Ther; 2020; 20(1):44-54. PubMed ID: 32416688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.